» Articles » PMID: 36768907

Coenzyme Q10 Metabolism: A Review of Unresolved Issues

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Feb 11
PMID 36768907
Authors
Affiliations
Soon will be listed here.
Abstract

The variable success in the outcome of randomised controlled trials supplementing coenzyme Q10 (CoQ10) may in turn be associated with a number of currently unresolved issues relating to CoQ10 metabolism. In this article, we have reviewed what is currently known about these factors and where gaps in knowledge exist that need to be further elucidated. Issues addressed include (i) whether the bioavailability of CoQ10 could be improved; (ii) whether CoQ10 could be administered intravenously; (iii) whether CoQ10 could be administered via alternative routes; (iv) whether CoQ10 can cross the blood-brain barrier; (v) how CoQ10 is transported into and within target cells; (vi) why some clinical trials supplementing CoQ10 may have been unsuccessful; and (vii) which is the most appropriate tissue for the clinical assessment of CoQ10 status.

Citing Articles

Spatial mapping of dextran sodium sulphate-induced intestinal inflammation and its systemic effects.

Adams L, Rasid O, Hulme H, Quon T, Burchmore R, Milling S FASEB J. 2025; 39(4):e70415.

PMID: 39989432 PMC: 11848815. DOI: 10.1096/fj.202402780R.


Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey.

Neugebauer J, Reinson K, Bellusci M, Park J, Hikmat O, Bertini E J Inherit Metab Dis. 2024; 48(1):e12805.

PMID: 39529390 PMC: 11670042. DOI: 10.1002/jimd.12805.


Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer.

Cristani M, Citarella A, Carnamucio F, Micale N Biomolecules. 2024; 14(8).

PMID: 39199418 PMC: 11352298. DOI: 10.3390/biom14081031.


Associations between Long-Term Dietary Coenzyme Q10 Intake and New-Onset Hypertension in Adults: Insights from a Nationwide Prospective Cohort Study.

Zhao D, Tian Z, Kuang H, Xu Y, Zheng Y, Zhong Z Nutrients. 2024; 16(15).

PMID: 39125357 PMC: 11313835. DOI: 10.3390/nu16152478.


Efficacy and Safety of Coenzyme Q10 Supplementation in Neonates, Infants and Children: An Overview.

Mantle D, Hargreaves I Antioxidants (Basel). 2024; 13(5).

PMID: 38790635 PMC: 11117623. DOI: 10.3390/antiox13050530.


References
1.
Hargreaves I, Lane A, Sleiman P . The coenzyme Q10 status of the brain regions of Parkinson's disease patients. Neurosci Lett. 2008; 447(1):17-9. DOI: 10.1016/j.neulet.2008.09.069. View

2.
Paredes-Fuentes A, Montero R, Codina A, Jou C, Fernandez G, Maynou J . Coenzyme Q Treatment Monitoring in Different Human Biological Samples. Antioxidants (Basel). 2020; 9(10). PMC: 7601005. DOI: 10.3390/antiox9100979. View

3.
Takahashi K, Ohsawa I, Shirasawa T, Takahashi M . Early-onset motor impairment and increased accumulation of phosphorylated α-synuclein in the motor cortex of normal aging mice are ameliorated by coenzyme Q. Exp Gerontol. 2016; 81:65-75. DOI: 10.1016/j.exger.2016.04.023. View

4.
Crooks S, Bech S, Halling J, Christiansen D, Ritz B, Petersen M . Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson's disease. Neurosci Lett. 2018; 675:116-119. DOI: 10.1016/j.neulet.2018.03.064. View

5.
Alcazar-Fabra M, Rodriguez-Sanchez F, Trevisson E, Brea-Calvo G . Primary Coenzyme Q deficiencies: A literature review and online platform of clinical features to uncover genotype-phenotype correlations. Free Radic Biol Med. 2021; 167:141-180. DOI: 10.1016/j.freeradbiomed.2021.02.046. View